
- Tissue
- Mammary gland
- Disease
- Carcinoma
- Metastatic site
- Metastatic (high metastatic potential; primarily to lungs)
- Synonyms
- Mouse Mammary Carcinoma Highly Metastatic Cell Line
Documents
MA-891
Cell line · Product number 305581
MA-891 is a highly metastatic murine mammary gland carcinoma cell line, established from a spontaneous mammary tumor in a mouse and selected for its aggre...
Customization / Recommendations
- MA-891Cell line€777.00
01General information
- Description
MA-891 is a highly metastatic murine mammary gland carcinoma cell line, established from a spontaneous mammary tumor in a mouse and selected for its aggressive metastatic behavior. The line grows as an adherent monolayer and is classified as a syngeneic tumor cell line compatible with immunocompetent mouse hosts, enabling in vivo studies of mammary carcinoma growth, metastasis, and immune interaction. MA-891 represents a highly metastatic variant selected for its propensity to disseminate to distant organs, particularly the lungs.
MA-891 is applicable in murine mammary carcinoma research including studies of metastatic cascade biology, invasion, angiogenesis, tumor-immune interactions, and preclinical evaluation of anti-metastatic and anti-tumor agents. Its syngeneic origin enables testing of immunotherapy approaches in immunocompetent hosts, including checkpoint inhibitor evaluation and cancer vaccine development. The high metastatic potential makes it a useful model for studying metastasis prevention strategies and the biology of aggressive mammary carcinoma.
- Tissue
- Mammary gland
- Disease
- Carcinoma
- Metastatic site
- Metastatic (high metastatic potential; primarily to lungs)
- Applications
- Murine mammary carcinoma research; metastasis biology; anti-metastatic drug evaluation; syngeneic tumor immunotherapy; tumor-immune interaction; cancer vaccine studies
- Synonyms
- Mouse Mammary Carcinoma Highly Metastatic Cell Line
02Classification
- Organism
- Mouse
- Sex
- Female
- Growth properties
- Adherent
- Biosafety level
- 1
03Characteristics
- Morphology
- Epithelial-like
- Cell type
- Tumor Cell Line
- Doubling time
- approx. 18 to 24 hours
04Identifiers
- Citation
- MA-891 (Cytion catalog number 305581)
- NCBI TaxID
- 10090
05Handling and culture
- Culture medium
- RPMI-1640 with 10% FBS; 1% Penicillin-Streptomycin Solution
- Incubation atmosphere
37°C, 5% CO2, humidified atmosphere.
- Supplements
- Supplement the medium with 10% FBS and 1% Penicillin-Streptomycin
- Dissociation reagent
- Accutase
- Subculturing
- Remove medium, wash with PBS without calcium and magnesium, cover with Accutase, incubate 8–10 min at RT, resuspend in medium, centrifuge 300×g 3 min, discard supernatant, reseed in fresh medium.
- Split ratio
- 1 to 5
- Seeding density
- 1 to 3 × 10⁴ cells/cm²
- Fluid renewal
- Every 2 to 3 days
- Thawing and culturing
Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.
Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.
For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.
Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.
Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.
Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.
Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.
Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.
06Quality control and cryopreservation
- Freeze medium
- As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
- Storage conditions
For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.
- Shipping conditions
Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.
07Donor
- Donor age
- Age unspecified
- Ethnicity
- Unspecified
08Legal and safety
- Safety precautions
- When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments.
- Warranty
At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.
For full details, please refer to our Warranty Statement.
- Material Transfer Agreement required
- Yes